Isolated elevation of aldolase in the serum of myositis patients: A potential biomarker of damaged early regenerating muscle cells

Clinical and Experimental Rheumatology

Volumn 30, Issue 4, 2012, Pages 548-553

  Casciola Rosen, L ^a   Hall, J C ^a   Mammen, A L ^a   Christopher Stine, L ^a   Rosen, A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aldolase; Creatine kinase; Muscle regeneration; Myositis

Indexed keywords

CARDIOTOXIN; CREATINE KINASE MM; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE ISOENZYME; MESSENGER RNA; RNA; UNCLASSIFIED DRUG;

ALDOLASE A GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL REGENERATION; CK GENE; CONTROLLED STUDY; CYTOLOGY; DISEASE MARKER; ENZYME BLOOD LEVEL; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE BIOPSY; MUSCLE CELL; MYOBLAST; MYOSITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BIOPSY; CELL DIFFERENTIATION; CELLS, CULTURED; CREATINE KINASE; DISEASE MODELS, ANIMAL; FRUCTOSE-BISPHOSPHATE ALDOLASE; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOSITIS; REGENERATION; UP-REGULATION;

EID: 84867381737     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. GUSEINOVA D, CONSOLARO A, TRAIL L et al.: Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis. Clin Exp Rheumatol 2011; 29: 117-24.
2. BOHAN A, PETER JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-7.
3. BOHAN A, PETER JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
4. LOTT JA, LANDESMAN PW: The enzymology of skeletal muscle disorders. Crit Rev Clin Lab Sci 1984; 20: 153-90.
5. FUJIMOTO M, SATO S, IHN H, KIKUCHI K, YAMADA N, TAKEHARA K: Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis. J Rheumatol 1995; 22: 563-5.
6. QUINTERO-DEL-RIO AI, PUNARO M, PASCUAL V: Faces of eosinophilic fasciitis in childhood. J Clin Rheumatol 2002; 8: 99-103.
7. CARTER JD, KANIK KS, VASEY FB, VALERIANO- MARCET J: Dermatomyositis with normal creatine kinase and elevated aldolase levels. J Rheumatol 2001; 28: 2366-7.
8. SATO S, HIRAKATA M, KUWANA M et al.: Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005; 52: 1571-6.
9. NOZAKI K, PESTRONK A: High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology. J Neurol Neurosurg Psychiatry 2009; 80: 904-8.
10. CASCIOLA-ROSEN L, NAGARAJU K, PLOTZ P et al.: Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005; 201: 591-601.
11. MAMMEN AL, CASCIOLA-ROSEN LA, HALL JC, CHRISTOPHER-STINE L, CORSE AM, ROSEN A: Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis Rheum 2009; 60: 3784-93.
12. MATHIESEN PR, ZAK M, HERLIN T, NIELSEN SM: Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin Exp Rheumatol 2010; 28: 782-89.
13. MAMMEN AL, CHUNG T, CHRISTOPHERSTINE L, ROSEN P, ROSEN A, CASCIOLAROSEN LA: Autoantibodies against 3-hydroxy- 3-methylglutaryl-coenzyme a reductase (HMGCR) in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011; 63: 713-21.
14. ZHAO P, HOFFMAN EP: Embryonic myogenesis pathways in muscle regeneration. Dev Dyn 2004; 229: 380-92.